USPTO serial 99254488
R&D SYSTEMS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 10, 2026
- Examiner
- NEWKIRK, MERIDITH E.
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with R&D SYSTEMS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MINNEAPOLIS, MN, US
MINNEAPOLIS, MN, US
MINNEAPOLIS, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Courtney Thompson
Courtney Thompson Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents and chemicals for scientific, medical research, clinical research, life science, research laboratory, and pharmaceutical research use; reagents, namely recombinant proteins and antibodies, for scientific, medical research, clinical research, life science, research laboratory, and pharmaceutical research use; biological cell culture material for scientific, medical research, clinical research, life science, research laboratory, and pharmaceutical research use; assays for research purposes; fluorescent dye for scientific, medical research, clinical research, life science, research laboratory, and pharmaceutical research use; oligonucleotides for scientific, medical research, clinical research, life science, research laboratory, pharmaceutical research use; enzymes for scientific and research purposes | ACTIVE | Nov 30, 1985 |
| 005 | Clinical medical reagents; reagents for medical diagnostic use; reagents, namely, recombinant proteins and antibodies, for medical diagnostic use; biological preparations for use in cell cultures for diagnostic medical use; fluorescent dye for diagnostic medical use; oligonucleotides for diagnostic medical use | ACTIVE | Nov 30, 1985 |
| 009 | Instrumentation for life science research, namely, instruments to identify, quantify, and characterize proteins, analyze particles in biological samples, perform immunoassays, and to dispense and characterize cells; instrumentation for life science research, namely, instruments for quality control and analysis in the manufacture of therapeutic products, namely, computer hardware, cytometry analyzers and sorters, real time PCR cyclers, sample preparers, mass cytometry analyzers, automated liquid handlers, multiplexers; multiplexers; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in microtiter plates; microplate readers in the nature of apparatuses and instruments used to detect and measure absorbance at different light wavelengths for immunoassays; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in plates for research, bioassays, drug discovery, and manufacturing; protein analysis equipment comprised of computer hardware, downloadable software, and electronic display screens for protein detection, imaging, and quantitative analysis for use in genetic research, antibody research, biomarker discovery, and biotherapeutics production; laboratory apparatus, namely, protein sample fractionators; computer hardware and peripherals; downloadable software for multiplexing in the nature of telecommunications and computer networking; laboratory apparatus, namely, laboratory apparatus for western blot processing of proteins | ACTIVE | Nov 30, 1985 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIO-TECHNE CORPORATION
- Other trademarks owned by BIO-TECHNE CORPORATION
- Other trademarks owned by BIO-TECHNE CORPORATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named R&D SYSTEMS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 22, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 16, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | IUAA | USE AMENDMENT ACCEPTED | — |
| Jun 30, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 30, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 30, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2026 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Jun 30, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jun 30, 2026 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Jun 22, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 26, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 26, 2025 | NWAP | NEW APPLICATION ENTERED | — |